Skip to main content

Table 1 Demographics and clinical characteristics of study subjects

From: Humoral and T cell responses to SARS-CoV-2 reveal insights into immunity during the early pandemic period in Pakistan

 

HG

COVID-19

PP

Demographics

 Number of subjects (n)

304

163

114

 Age (years)

30.34 ± 12.02

34.73 ± 2.82

42.8. ± 14.7

 Sex (% females)

59.2

35.5

49.7

Clinical Characteristics

 Fever/chills (%)

-

47.23

-

 Cough (%)

-

27.60

-

 Sore throat (%)

-

21.47

-

 Shortness of breath (%)

-

10.42

-

 loss of taste/ smell (%)

-

0.61

-

Comorbid

 Diabetes (%)

0.01

3.06

-

 Hypertension (%)

0.02

3.06

-

 Asthma (%)

0.02

0.61

-

 Othersa (%)

1.97

5.52

 
  1. HG Healthy control Group (n = 304); COVID-19 (n = 163), PP pre-pandemic controls (n = 114). Data are presented as numbers (n), percentage (%) or median (interquartile range), unless otherwise stated. Othersa denote comorbid conditions including individuals with hypothyroidism, Grave's disease, Celiac disease, hyperlipidemia and thalassemia minor. Statistical analysis between groups was performed using the Kruskal Wallis test, p ≤ 0.05 was considered significant, ‘ns’ not significant
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us